AstraZeneca Canada
Gaby Bourbara, President
“As a long-standing partner of the ACT Foundation, we’re incredibly proud of their great work and progress to empower Canadian high school students across the country by teaching them critical lifesaving skills in the areas of CPR and AED training.”
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals. In Canada, the company employs more than 2,400 people and was recently named one of Canada’s Top 100 Employers for the second consecutive year. Together, AstraZeneca’s R&D Hub and the Alexion, AstraZeneca Rare Disease Development Hub – both based in Mississauga, Ontario – are leading more than 210 global clinical studies in areas such as breast, lung and prostate cancer, COPD, chronic kidney disease, and rare disease. Visit www.astrazeneca.ca for more information.
Amgen Canada
Ugur Gunaydin, General Manager
“We are proud to help students learn life-saving skills for life-threatening emergencies, but more importantly, to become champions for health and science in their families and communities. We strongly believe in the power of young people to inspire wellness. The ACT Program creates leaders, sparks innovative thinking and saves lives.”
Amgen applies science and innovation to help fight serious illness and dramatically improve people’s lives. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen has been an important contributor to Canada’s biotechnology sector since 1991.
For more information, please visit the company’s website at www.amgen.ca.
